Villere ST Denis J & Co. LLC Has $26.96 Million Position in Colgate-Palmolive (NYSE:CL)

Villere ST Denis J & Co. LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 2.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 259,683 shares of the company’s stock after selling 6,008 shares during the period. Colgate-Palmolive comprises about 2.2% of Villere ST Denis J & Co. LLC’s investment portfolio, making the stock its 24th largest holding. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $26,958,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. SpiderRock Advisors LLC boosted its position in shares of Colgate-Palmolive by 1.2% during the third quarter. SpiderRock Advisors LLC now owns 36,749 shares of the company’s stock worth $3,815,000 after buying an additional 437 shares during the period. CWA Asset Management Group LLC acquired a new position in Colgate-Palmolive during the third quarter valued at approximately $2,677,000. AEGON ASSET MANAGEMENT UK Plc boosted its position in Colgate-Palmolive by 38.9% during the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 1,165,104 shares of the company’s stock valued at $120,913,000 after purchasing an additional 326,348 shares during the last quarter. Leavell Investment Management Inc. boosted its position in Colgate-Palmolive by 0.9% during the third quarter. Leavell Investment Management Inc. now owns 40,584 shares of the company’s stock valued at $4,213,000 after purchasing an additional 353 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the third quarter valued at approximately $53,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $92.59 on Friday. The stock has a market cap of $75.65 billion, a P/E ratio of 26.53, a PEG ratio of 3.34 and a beta of 0.42. The stock has a 50 day simple moving average of $100.91 and a 200 day simple moving average of $98.37. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $74.67 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.16%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CL. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Sanford C. Bernstein increased their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Barclays increased their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.